OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ATNM

Stock ticker: ASE

PRICE

CHANGE

CAPITALIZATION

Actinium Pharmaceuticals (ATNM) Earnings Date & Reports

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ATNM is expected to report earnings to rise 64.77% to -36 cents per share on November 24

Actinium Pharmaceuticals ATNM Stock Earnings Reports

Q3'25

Est.

$-0.36

Q2'25

Beat

by $0.13

Q1'25

Missed

by $0.13

Q4'24

Beat

by $0.16

Q3'24

Est.

$-0.37

The last earnings report on August 14 showed earnings per share of -21 cents, beating the estimate of -34 cents. With 103.74K shares outstanding, the current market capitalization sits at 51.47M.

View a ticker or compare two or three

Compare

ATNM

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ATNM
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ATNM showed earnings on August 14, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

100 Park Avenue

Phone

+1 646 677-3870

Employees

Web

https://www.actiniumpharma.com